noscript

News and Announcements

Richard Hopkins appointed Phylogica CEO

  • Published July 19, 2013 10:48AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

PERTH, AUSTRALIA: 19 July 2013: Leading Australian peptide drug discovery company Phylogica Limited (ASX:PYC, XETRA:PH7) has appointed Dr Richard Hopkins as the company’s new Chief Executive Officer as part of a broad company strategic review. He will be appointed to the Board effective immediately.

Dr Hopkins has been with Phylogica since 2006, where he has served in variety of positions, most recently as Chief Scientific Officer (CSO). Dr Hopkins has worked with the phylomer platform for over 12 years and is a founding shareholder in Phylogica. Prior to that, he held senior research roles including with the Telethon Institute for Child Health Research, Department of Medicine at the University of Western Australia and Murdoch University.

To read the full ASX announcement, please download the document below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now